GSK3B and breast carcinoma: Besides NSCLC, G3BP1 was reported to participate in proliferation of breast cancer by coordinating with GSK-3β and stabilizing β-catenin 11, and peripheral myelin protein 22 (PMP22) was also considered to be involved in 46.